Drug intelligence / Profile preview

Cannabics

Development stage
Unknown
Lead developer
CNBX Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Cannabics is a standardized medical cannabis extract in capsule form developed by Cannabics Pharmaceuticals for the treatment of cancer-related cachexia and anorexia syndrome (CACS). The formulation contains a specific ratio of cannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC acts as a partial agonist at the Cannabinoid receptor 1 (CB1), which is known to stimulate appetite and modulate energy metabolism, while CBD provides complementary effects and may mitigate some of the psychoactive side effects of THC. The drug was evaluated in a Phase 2 pilot study to assess its ability to improve appetite and prevent weight loss in advanced cancer patients.

Brand names
Cannabics
Other names
Cannabics capsulesCannabis extract capsulesMedical cannabis capsules
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Cannabics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannabics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call